STOXX^® Europe Sustainability ex Alcohol Gambling Tobacco Armaments & Firearms

Companies that measure their environmental risk are better equipped to mitigate those risks. Those that are transparent about it and disclose this information provide critical insights to change market behavior. The STOXX Reported Low Carbon Indices cover only stocks with available reported carbon intensity data from companies, which are publicly committed to disclose their carbon emissions. These indices cover the regions Global, Europe, Eurozone and the USA. The indices have a variable number of components, and are price weighted with a weight factor based on the free-float market cap multiplied by the corresponding Z-score carbon intensity factor of each constituent. Components with lower carbon intensities are overweighted, while those with higher carbon emission are underweighted. The indices also exlcude companies violating international norms, are involved with controversial weapons, tobacco, thermal coal, civilian firearms, military equipment, and unconventional oil and gas.

STOXX uses  ISS ESG as reliable and professional data sources for the estimated and reported data. Data considered comprise Scope 1 (All direct GHG emissions) and Scope 2 (Indirect GHG emissions from consumption of purchased electricity, heat or steam) emissions.

STOXX calculates a comprehensive family of Low Carbon Indices. Click here to see all available indices.

Index Guides, Benchmark statement, and other reports are available under the Data tab.

The index aims to replicate an investment in the iSTOXX Transatlantic EU ESG 70 and iSTOXX Transatlantic US ESG 30 indices, with a daily reweighting respectively to 70% and 30%.

Index Guides, Benchmark statement, and other reports are available under the Data tab.

The ECPI Global ESG Silver Economy Index is designed to offer investors exposure to listed companies in global developed markets characterized by a positive ESG profile and that are the ones best placed to grasp the benefits deriving from life expectancy increase and aging population, pharmaceutical and medical innovation, changes in lifestyle and spending capacity of elderly cohorts of population.

Index Guides, Benchmark statement, and other reports are available under the Data tab.

Index Guides, Benchmark statement, and other reports are available under the Data tab.